Form 4: Protagonist CEO Gifts Shares to Grandchild

Protagonist Therapeutics CEO Dinesh V. Patel gifted 440 shares of common stock to his grandchild on November 21, 2025.

Summary

• Dinesh V. Patel, President and CEO, and a Director of Protagonist Therapeutics, Inc. (PTGX), reported a change in beneficial ownership.
• On November 21, 2025, Patel disposed of 440 shares of Protagonist Therapeutics Common Stock.
• The transaction was a bona fide gift of securities to his grandchild, with a reported price of $0 per share.
• Following this transaction, Patel beneficially owns 519,543 shares of Common Stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine insider gift of a small portion of shares, which is a neutral event for company valuation and does not reflect operational performance.

Positives

• The transaction was a gift, not a sale, indicating no direct cash outflow for the reporting person from the company.
• The remaining beneficial ownership of 519,543 shares is substantial, suggesting continued alignment with shareholder interests.

Negatives

• A reduction in direct beneficial ownership, even if a gift, slightly decreases the insider's direct stake in the company.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Management Comments

• The transaction involves a bona fide gift of securities from the Reporting Person to his grandchild.

Industry Context

This is a routine insider transaction report and does not provide information directly related to broader industry trends or competitive landscape.

Related Party Transactions

• Gift of 440 shares of common stock from CEO Dinesh V. Patel to his grandchild.

Stakeholder Impact

• Shareholders: Minimal impact due to the small number of shares gifted relative to the total outstanding shares and the CEO's remaining significant stake.
• Employees, Customers, Suppliers, Creditors: No direct impact from this personal transaction.

Key Dates

Recommendation

The Form 4 reports a routine insider gift of a small number of shares by the CEO to a grandchild. This transaction is not indicative of company performance or a significant change in the CEO's overall commitment, thus it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Protagonist Therapeutics, PTGX, Dinesh V. Patel, Insider Transaction, Form 4, Stock Gift, Beneficial Ownership, CEO, Director